• Name: Solomon Zeleke, Ph.D.
  • Institution: Idaho State University
  • Department: Biomedical and Pharmaceutical Sciences
  • Phone: 208-380-3779
  • Email: solomonzeleke@isu.edu

Summary: My medicinal chemistry research program investigates the discovery and development of small-molecule inhibitors targeting cyclin-dependent kinases (CDKs). I have identified novel clinical stage CDK4-, CDK4/6-, and CDK12-selective inhibitors as candidate therapeutics for cancer. I am interested in the design and synthesis of CDK-selective inhibitors, and my current efforts are focused on discovering novel CDK-selective inhibitors and degraders.

Minimum Courses: N/A

Projects: Design and synthesis of CDK-selective inhibitors. In my lab, students will learn a range of practical skills and theoretical knowledge related to the design, synthesis, and analysis of chemical compounds with potential medicinal properties.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search